A double-blind trial to investigate the effects of Thorazine (Largactil, chlorpromazine), Compazine (Stemetil, prochlorperazine) and Stelazine (trifluoperazine) in paranoid schizophrenia.
نویسندگان
چکیده
IN the early phenothiazine literature the ataractic properties of Thorazine in the control of disturbed, hyperactive schizophrenics were described (Kurland, 1955; Hall and Dunlap, 1955; Lehmann, 1955). Kurland (1955) gives an excellent description of the powerful activity ofThorazineinthis sphere, namely the control of hyperkinesis and hostile, aggressive behaviour; however, he found that there was little basic change in delusional thought disorder other than to divorce the abnormal thinking from its affective attachment. It was noted that the clinical improvement was most dramatic when the affective component of the illness was most marked. Hall and Dunlap (1955) felt that there was significant reduc tion in delusional ideation but noted that the schizophrenic process was not affected by Thorazine medication. With Compazine (Stemetil) stress was laid on different spheres of thera peutic activity, namely in the control of abnormal thought content and in influencing psychomotor activity. Compazine was reported as having active therapeutic properties in the amelioration of delusional ideation and hallucina tions (Mime and Berliner, 1958; Denham, 1958; Winkelman, 1959). It would appear that Compazine has the dual ability to inhibit hyper-motility and to stimulate activity in the underactive patient. Freyhan (1958) found that it had a highly selective action in hyperkinetic syndromes, but other authors (Mime and Berliner, 1958 and Frierson, 1958) found it equally effective in counteracting * dull, withdrawn, apathetic, asocial and negativistic behaviour. In a comparative study of chlorpromazine (Thorazine-Largactil) and prochlorperazine (Com pazine-Stemetil), Dransfield (1958) found these drugs equally effective in con trolling hostile, aggressive, hyperactive behaviour; however, he found chlor promazine superior to prochiorperazine in counteracting apathy. It would appear that few toxic side-effects, for example bone marrow and liver toxicity (Wilcox, 1955), have been recorded with Compazine and it also had the advantage of producing less somnolence than Thorazine. The predominant side-effects were
منابع مشابه
Effects of Bromocriptine on Negative Symptoms of Schizophrenia: A Double Blind Clinical Trial
Negative symptoms are still a major obstacle in the recovery of schizophrenic patients. Many attempts to develop novel drugs affecting negative symptoms of schizophrenia have yielded insignificant results. This study evaluates the effects of bromocriptine, a dopamine agonist, on negative symptoms of schizophrenia utilizing a placebo-controlled crossover double-blind clinical trial. Methodology:...
متن کاملEffects of Atorvastatin on negative sign in chronic schizophrenia: A double blind clinical trial
The aim of this study was to evaluate the effects of Atorvastatin on negative symptoms in patients with chronic schizophrenia. The study was a prospective, double-blind, 6-week trial. Forty patients participated in the study; 19 patients were assigned to the Atorvastatin group as well as 21 patients to the placebo group. For assessing negative signs, we used Scale for the Assessment of Negative...
متن کاملEffects of Atorvastatin on negative sign in chronic schizophrenia: A double blind clinical trial
The aim of this study was to evaluate the effects of Atorvastatin on negative symptoms in patients with chronic schizophrenia. The study was a prospective, double-blind, 6-week trial. Forty patients participated in the study; 19 patients were assigned to the Atorvastatin group as well as 21 patients to the placebo group. For assessing negative signs, we used Scale for the Assessment of Negative...
متن کاملEffects of metformin on weight loss and metabolic control in obese patients with schizophrenia and schizoaffective disorder: a randomized, double-blind, controlled clinical trial
Abstract Objective: The effect of metformin on weight changes and some metabolic parameters in patients with schizophrenia and schizoaffective disorder was investigated in this study. Methods: This study, performed during 2018-2019, was a randomized, double-blind, controlled clinical trial. A total of 66 obese patients (BMI≥27) with schizophrenia and schizoaffective disorder, hospitalized in...
متن کاملTreatment-Responsiveness of Negative Symptoms in Schizophrenia: A double-blind placebo-control clinical trial
Background: The negative symptoms of schizophrenia remain a major clinical challenge. Nortriptyline is a serotonin and noradrenalin reuptake inhibitor and belongs to secondary amine tricycles. The aim of this study is to evaluate the effect of nortriptyline on the negative symptoms of schizophrenia. Methods: This study is a six-week randomized placebo-control trial of nortriptyline or placebo a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of mental science
دوره 107 شماره
صفحات -
تاریخ انتشار 1961